We are live on
!
Find out more
ALDR
Alder Biopharmaceuticals
ALDR
ALDR
Delisted
ALDR was delisted on the 21st of October, 2019.
140 hedge funds and large institutions have $1.22B invested in Alder Biopharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 33 funds opening new positions, 62 increasing their positions, 35 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
77% more repeat investments, than reductions
Existing positions increased: 62 | Existing positions reduced: 35
74% more first-time investments, than exits
New positions opened: 33 | Existing positions closed: 19
10% more funds holding
Funds holding: 127 → 140 (+13)
25% less funds holding in top 10
Funds holding in top 10: 4 → 3 (-1)
28% less capital invested
Capital invested by funds: $1.69B → $1.22B (-$471M)
73% less call options, than puts
Call options by funds: $2.4M | Put options by funds: $8.78M
Holders
140
Holders Change
+13
Holders Change %
+10.24%
% of All Funds
3.91%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.08%
New
33
Increased
62
Reduced
35
Closed
19
Calls
$2.4M
Puts
$8.78M
Net Calls
-$6.37M
Net Calls Change
-$2.55M
Top Buyers
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$103M |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$16.1M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$14M |
| 4 |
EAM
Eagle Asset Management
St Petersburg,
Florida
|
-$9.64M |
| 5 |
PC
PointState Capital
New York
|
-$7.95M |
